Lipid Metabolism Disorders D052439

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders

Description

Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.   MeSH

Hierarchy View

Subtype Terms (5)

Dyslipidemias
245 drugs (71 approved, 174 experimental)

Lipid Metabolism, Inborn Errors
5 drugs (2 approved, 3 experimental)

Lipodystrophy
31 drugs (25 approved, 6 experimental)

Lipomatosis
 


Phase 3 Indicated Drugs (1)

Phase 2 Indicated Drugs (2)


Organization Involved with Phase 2 Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.